Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) in Hodgkin's disease: Report of a case

Tumori

Volumn 90, Issue 5, 2004, Pages 517-520

  Guliter, Sefa ^a,c   Erdem, Ozlem ^b   Isik, Mine ^b   Yamac, Kadri ^b   Uluoglu, Omer ^b  

^a KIRIKKALE UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY   (Turkey)

^c Aydinlikevler Mahallesi   (Turkey)

Author keywords

Ductopenia; Hodgkin's disease; Intrahepatic cholestasis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; BIOCHEMICAL MARKER; BLEOMYCIN; DACARBAZINE; DOXORUBICIN; GAMMA GLUTAMYLTRANSFERASE; PREDNISOLONE; URSODEOXYCHOLIC ACID; VINCRISTINE;

ADULT; ARTICLE; BILE DUCT DISEASE; BLOOD CHEMISTRY; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; INTRAHEPATIC CHOLESTASIS; LAPAROTOMY; LIVER BIOPSY; LYMPHADENOPATHY; MALE; OBSTRUCTIVE JAUNDICE; SEPSIS; VANISHING BILE DUCT SYNDROME;

EID: 9344244072     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160409000516     Document Type: Article

References (24)

1. Bagley CM Jr, Thomas LB, Johnson RE, Chretien PB, de Vita VT Jr: Diagnosis of liver involvement by lymphoma: results in 96 consecutive peritoneoscopies. Cancer, 31: 840-847, 1973.
2. Levitan R, Diamond HD, Craver LF: Jaundice in Hodgkin's disease. Am J Med, 30: 99-111, 1961.
3. Birrer MJ, Young RC: Differential diagnosis of jaundice in lymphoma patients. Semin Liver Dis, 3: 269-277, 1987.
4. Perera DR, Greene ML, Fenster LF: Cholestasis associated with extrabiliary Hodgkin's disease. Gastroenterology, 67: 680-685, 1974.
5. Martin KR, Moore TJ, Wright AR: Obstructive jaundice secondary to primary involvement with Hodgkin's disease. Am J Gastroenterol, 87: 1194-1195, 1992.
6. Lieberman DA: Intrahepatic cholestasis due to Hodgkin's disease: an elusive diagnosis. J Clin Gastroenterol, 8: 304-307, 1986.
7. Hubscher SG, Lumley MA, Elias GA: Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma. Hepatology, 17: 70-77, 1993.
8. Sherlock S: The syndrome of disappearing intrahepatic bile ducts. Lancet, 2: 493-496, 1987.
9. Alam I, Ferrell LD, Bass NM: Vanishing bile duct syndrome temporally associated with ibuprofen use. Am J Gastroenterol, 91: 1626-1630, 1996.
10. De Galoscy C, Horsmans Y, Rahier J, Geubel AP: Vanishing bile duct syndrome occurring after carbamazepine administration: a second case report. J Clin Gastroenterol, 19: 269-271, 1994.
11. Moradpour D, Altorfer J, Flury Rgreminger P, Meyenberger C, Jost R, Schmid M: Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis. Hepatology, 20: 1437-1441, 1994.
12. Altraif I, Lily L, Wanless IR, Heatcote J: Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) after administration of clindamycin and trimethoprim-sulfamethoxazole. Am J Gastroenterol, 89: 1230-1234, 1994.
13. Hunt CM, Washington K: Tetracycline-induced bile duct paucity and prolonged cholestasis. Gastroenterology, 107: 1844-1847, 1994.
14. Leblanc A, Hadchouel M, Jehan P, Odievre M, Alagille D: Obstructive jaundice in children with histiocytosis X. Gastroenterology, 80: 134-139, 1981.
15. Waterson J, Priest JR: Jaundice as a paraneoplastic phenomenon in a T-cell lymphoma. Gastroenterology, 97: 1319-1322, 1989.
16. Ludwig J, Wiesner RH, LaRusso NF: Idiopathic adulthood ductopenia: a cause of chronic cholestatic liver disease and biliary cirrhosis. J Hepatol, 7: 193-199, 1988.
17. Crosbie OM, Crown JP Nolan NPM, Murray R, Hegarty JE: Resolution of paraneoplastic bile duct paucity following successful treatment of Hodgkin's disease. Hepatology, 26: 5-8, 1997.
18. Warner AS, Whitcomb FF: Extrahepatic Hodgkin's disease and cholestasis. Am J Gastroenterol, 89: 940-941, 1994.
19. Liangpunsakul S, Kwo P, Koukoulis GK: Hodgkin's disease presenting as cholestatic hepatitis with prominent ductal injury. Eur J Gastroenterol Hepatol, 14: 323-327, 2002.
20. Komurcu S, Ozet A, Altundag MK, Arpaci F, Ozturk B, Celasun B, Tezcan Y: Vanishing bile duct syndrome occurring after high-dose chemotherapy and autologous peripheral stem cell transplantation in a patient with Hodgkin's disease. Ann Hematol, 81:57-58, 2002.
21. Ripoll C, Carretero L, Sabin P, Alvarez E, Marrupe D, Banares R: Idiopathic cholestasis associated with progressive ductopenia in two patients with Hodgkin's disease. Gastroenterol Hepatol, 25: 313-315, 2002.
22. Allory Y, Metreau J, Zafrani E: Paraneoplastic vanishing bile duct syndrome in a case of Hodgkin's disease. Ann Pathol. 20: 52-55, 2000.
23. De Medeiros BC, Lacerda MA, Telles JE, da Suva JA, de Medeiros CR: Cholestasis secondary to Hodgkin's disease: report of 2 cases of vanishing bile duct syndrome. Haematologica, 83: 1038-1040, 1998.
24. O'Brien CB, Shields DS, Saul SH, Reddy KR: Drug-induced vanishing bile duct syndrome: response to ursodiol. Am J Gastroenterol, 91: 1456-1457, 1996.